Impact Biomedical, Stock Performance
| IBO Stock | USD 1.80 0.05 2.70% |
On a scale of 0 to 100, Impact BioMedical, holds a performance score of 6. The company retains a Market Volatility (i.e., Beta) of 2.52, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Impact BioMedical, will likely underperform. Please check Impact BioMedical,'s downside variance, and the relationship between the treynor ratio and kurtosis , to make a quick decision on whether Impact BioMedical,'s current trending patterns will revert.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Impact BioMedical, are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental drivers, Impact BioMedical, displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Disposition of 500 shares by Dss, Inc. of Impact BioMedical, at 2.757 subject to Rule 16b-3 | 11/12/2024 |
2 | Disposition of 200 shares by Dss, Inc. of Impact BioMedical, at 2.8 subject to Rule 16b-3 | 11/13/2024 |
3 | Disposition of 5000 shares by Dss, Inc. of Impact BioMedical, at 3.017 subject to Rule 16b-3 | 11/18/2024 |
4 | Acquisition by Heuszel Frank D of 550 shares of Impact BioMedical, at 2.625 subject to Rule 16b-3 | 11/26/2024 |
5 | Acquisition by Heuszel Frank D of 500 shares of Impact BioMedical, at 2.61 subject to Rule 16b-3 | 11/27/2024 |
6 | Acquisition by Heuszel Frank D of 500 shares of Impact BioMedical, at 2.2578 subject to Rule 16b-3 | 12/05/2024 |
7 | Discretionary transaction by Dss, Inc. of tradable shares of Impact BioMedical, subject to Rule 16b-3 | 01/06/2025 |
| Begin Period Cash Flow | 2000.00 |
Impact |
Impact BioMedical, Relative Risk vs. Return Landscape
If you would invest 157.00 in Impact BioMedical, on October 10, 2024 and sell it today you would earn a total of 23.00 from holding Impact BioMedical, or generate 14.65% return on investment over 90 days. Impact BioMedical, is generating 0.8932% of daily returns assuming volatility of 11.3662% on return distribution over 90 days investment horizon. In other words, majority of equities are less volatile than Impact, and most equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Impact BioMedical, Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Impact BioMedical,'s investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Impact BioMedical,, and traders can use it to determine the average amount a Impact BioMedical,'s price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0786
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | IBO | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 11.37 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.89 actual daily | 17 83% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Impact BioMedical, is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Impact BioMedical, by adding it to a well-diversified portfolio.
Impact BioMedical, Fundamentals Growth
Impact Stock prices reflect investors' perceptions of the future prospects and financial health of Impact BioMedical,, and Impact BioMedical, fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Impact Stock performance.
| Return On Equity | 0.0345 | ||||
| Return On Asset | -0.0499 | ||||
| Current Valuation | 26.68 M | ||||
| Shares Outstanding | 11.5 M | ||||
| Price To Book | 0.68 X | ||||
| EBITDA | (2.82 M) | ||||
| Net Income | (4.34 M) | ||||
| Total Debt | 12.07 M | ||||
| Book Value Per Share | 2.72 X | ||||
| Cash Flow From Operations | (2.85 M) | ||||
| Earnings Per Share | 0.10 X | ||||
| Market Capitalization | 21.28 M | ||||
| Total Asset | 44.63 M | ||||
| Retained Earnings | (12.96 M) | ||||
| Working Capital | (12.8 M) | ||||
About Impact BioMedical, Performance
By examining Impact BioMedical,'s fundamental ratios, stakeholders can obtain critical insights into Impact BioMedical,'s financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Impact BioMedical, is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.91) | (2.01) | |
| Return On Capital Employed | 0.10 | 0.11 | |
| Return On Assets | (1.91) | (2.01) | |
| Return On Equity | (3.06) | (3.21) |
Things to note about Impact BioMedical, performance evaluation
Checking the ongoing alerts about Impact BioMedical, for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Impact BioMedical, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Impact BioMedical, is way too risky over 90 days horizon | |
| Impact BioMedical, may become a speculative penny stock | |
| Impact BioMedical, appears to be risky and price may revert if volatility continues | |
| Impact BioMedical, has high likelihood to experience some financial distress in the next 2 years | |
| Reported Net Loss for the year was (4.34 M) with profit before taxes, overhead, and interest of 0. | |
| Impact BioMedical, generates negative cash flow from operations | |
| Impact BioMedical, has a frail financial position based on the latest SEC disclosures | |
| About 55.0% of the company shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Discretionary transaction by Dss, Inc. of tradable shares of Impact BioMedical, subject to Rule 16b-3 |
- Analyzing Impact BioMedical,'s financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Impact BioMedical,'s stock is overvalued or undervalued compared to its peers.
- Examining Impact BioMedical,'s industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Impact BioMedical,'s management team can have a significant impact on its success or failure. Reviewing the track record and experience of Impact BioMedical,'s management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Impact BioMedical,'s stock. These opinions can provide insight into Impact BioMedical,'s potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impact BioMedical,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. To learn how to invest in Impact Stock, please use our How to Invest in Impact BioMedical, guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Impact BioMedical,. If investors know Impact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Impact BioMedical, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Impact BioMedical, is measured differently than its book value, which is the value of Impact that is recorded on the company's balance sheet. Investors also form their own opinion of Impact BioMedical,'s value that differs from its market value or its book value, called intrinsic value, which is Impact BioMedical,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Impact BioMedical,'s market value can be influenced by many factors that don't directly affect Impact BioMedical,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Impact BioMedical,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Impact BioMedical, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Impact BioMedical,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.